Recursion Pharmaceuticals, Inc. RXRX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s investing cash flow?
- Recursion Pharmaceuticals, Inc. (RXRX) reported investing cash flow of -$338K in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s investing cash flow increased by 95.4% year-over-year, from -$7.27M to -$338K.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s investing cash flow has grown at a -50.1% compound annual growth rate (CAGR), from -$271.74M to -$16.87M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.